Penny-wise but Pound-foolish: The Hidden Costs of Step Therapy for Overactive Bladder. Letter.

No AccessJournal of UrologyLetters to the Editor7 Aug 2023Penny-wise but Pound-foolish: The Hidden Costs of Step Therapy for Overactive Bladder. Letter. Jennifer L. Gruenenfelder Jennifer L. GruenenfelderJennifer L. Gruenenfelder *Correspondence: More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003640AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookLinked InTwitterEmail "Penny-wise but Pound-foolish: The Hidden Costs of Step Therapy for Overactive Bladder. Letter.." The Journal of Urology, Publish Ahead of Print, pp. REFERENCES 1. . Penny-wise but pound-foolish: the hidden costs of step therapy for overactive bladder. J Urol.2023; 209(6):1045-1047. Link, Google Scholar 2. . Erectile dysfunction: AUA guideline. J Urol.2018; 200(3):633-641. Link, Google Scholar 3. . Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART I—initial work-up and medical management. J Urol.2021; 206(4):806-817. Link, Google Scholar 4. . Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment 2019. J Urol.2019; 202(3):558-563. Link, Google Scholar 5. . Long-term patterns of use and treatment failure with anticholinergic agents for overactive bladder. Clin Ther.2013; 35(11):1744-1751. Crossref, Medline, Google Scholar Support: None. Conflict of Interest: Abbvie Pharmaceuticals: Speaker bureau. Ethics Statement: No ethics committee approval was necessary as this does not involve human subjects research. Author Contributions: Jennifer Gruenenfelder contributed 100% of the manuscript contents. © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Jennifer L. Gruenenfelder *Correspondence: More articles by this author Expand All Support: None. Conflict of Interest: Abbvie Pharmaceuticals: Speaker bureau. Ethics Statement: No ethics committee approval was necessary as this does not involve human subjects research. Author Contributions: Jennifer Gruenenfelder contributed 100% of the manuscript contents. Advertisement PDF downloadLoading ...